Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the Literature.

Funasaka C, Kanemasa Y, Shimoyama T, Ohta A, Omuro Y.

Case Rep Oncol. 2019 Aug 16;12(2):657-665. doi: 10.1159/000502512. eCollection 2019 May-Aug.

2.

Relative dose intensity of R-CHOP therapy and patient outcomes in advanced follicular lymphoma.

Konishi T, Kanemasa Y, Sasaki Y, Okuya T, Yamaguchi T, Funasaka C, Shimoyama T, Omuro Y.

Hematol Oncol. 2019 Aug;37(3):303-307. doi: 10.1002/hon.2614. Epub 2019 Apr 26. No abstract available.

PMID:
30933366
3.

Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma.

Kanemasa Y, Shimoyama T, Sasaki Y, Hishima T, Omuro Y.

Ann Hematol. 2018 Jun;97(6):999-1007. doi: 10.1007/s00277-018-3273-1. Epub 2018 Feb 9.

PMID:
29427185
4.

A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas.

Kaito S, Kanemasa Y, Sasaki Y, Okuya T, Yamaguchi T, Funasaka C, Shimoyama T, Omuro Y, Hishima T, Maeda Y.

Int J Hematol. 2018 Apr;107(4):451-459. doi: 10.1007/s12185-017-2362-6. Epub 2017 Nov 4.

PMID:
29103138
5.

PET Imaging of 18F-FDG, 11C-methionine, 11C-flumazenil, and 11C-4DST in Progressive Multifocal Leukoencephalopathy.

Ishibashi K, Miura Y, Matsumura K, Kanemasa Y, Nakamichi K, Saijo M, Toyohara J, Ishii K.

Intern Med. 2017;56(10):1219-1223. doi: 10.2169/internalmedicine.56.8080. Epub 2017 May 15.

6.

Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients.

Kanemasa Y, Shimoyama T, Sasaki Y, Tamura M, Sawada T, Omuro Y, Hishima T, Maeda Y.

Hematol Oncol. 2018 Feb;36(1):76-83. doi: 10.1002/hon.2426. Epub 2017 Apr 27.

PMID:
28449294
7.

Analysis of prognostic value of complete response by PET-CT and further stratification by clinical and biological markers in DLBCL patients.

Kanemasa Y, Shimoyama T, Sasaki Y, Tamura M, Sawada T, Omuro Y, Hishima T, Maeda Y.

Med Oncol. 2017 Feb;34(2):29. doi: 10.1007/s12032-017-0885-6. Epub 2017 Jan 12.

PMID:
28083854
8.

The impacts of initial and relative dose intensity of R-CHOP on outcomes of elderly patients with diffuse large B-cell lymphoma.

Kanemasa Y, Shimoyama T, Sasaki Y, Tamura M, Sawada T, Omuro Y, Hishima T, Maeda Y.

Leuk Lymphoma. 2017 Mar;58(3):736-739. doi: 10.1080/10428194.2016.1211279. Epub 2016 Aug 11. No abstract available.

PMID:
27686739
9.

Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic model.

Kanemasa Y, Shimoyama T, Sasaki Y, Tamura M, Sawada T, Omuro Y, Hishima T, Maeda Y.

Ann Hematol. 2016 Oct;95(10):1661-9. doi: 10.1007/s00277-016-2744-5. Epub 2016 Jul 2.

PMID:
27370993
10.

Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma.

Kanemasa Y, Shimoyama T, Sasaki Y, Tamura M, Sawada T, Omuro Y, Hishima T, Maeda Y.

Hematol Oncol. 2017 Dec;35(4):440-446. doi: 10.1002/hon.2312. Epub 2016 May 30.

PMID:
27238634
11.

A convenient prognostic score consisting of the Glasgow prognostic score and serum lactate dehydrogenase predicts clinical outcome in patients with diffuse large B-cell lymphoma.

Kanemasa Y, Shimoyama T, Sasaki Y, Sawada T, Omuro Y, Hishima T, Maeda Y.

Leuk Lymphoma. 2016 Oct;57(10):2460-3. doi: 10.3109/10428194.2016.1143940. Epub 2016 Feb 17. No abstract available.

PMID:
26886828
12.

[Peripheral neuropathy].

Kanemasa Y, Maeda Y.

Nihon Rinsho. 2015 Feb;73 Suppl 2:470-4. Japanese. No abstract available.

PMID:
25831805
13.

Long-term complete remission in a patient with intravascular large B-cell lymphoma with central nervous system involvement.

Sawada T, Omuro Y, Kobayashi T, Hishima T, Koizumi F, Kanemasa Y, Shimoyama T, Sasaki E, Maeda Y.

Onco Targets Ther. 2014 Nov 18;7:2133-6. doi: 10.2147/OTT.S72596. eCollection 2014.

14.

Mixed acinar-endocrine carcinoma of the pancreas treated with S-1.

Kanemasa Y, Kamisawa T, Tabata T, Kuruma S, Iwasaki S, Chiba K, Kuwata G, Fujiwara T, Egashira H, Koizumi K, Fujiwara J, Arakawa T, Momma K, Rokutan H, Horiguchi S, Hishima T.

Clin J Gastroenterol. 2013 Dec;6(6):459-64. doi: 10.1007/s12328-013-0416-8. Epub 2013 Sep 5.

PMID:
26182137
15.

[Effects of internal working models of attachment on cognition about facial expressions].

Shima Y, Fukui Y, Kanemasa Y, Nomura M, Mugiyama T.

Shinrigaku Kenkyu. 2012 Jun;83(2):75-81. Japanese.

PMID:
22834083
16.

A case of diabetic ketoacidosis associated with Guillain-Barré syndrome.

Kanemasa Y, Hamamoto Y, Iwasaki Y, Kawasaki Y, Honjo S, Ikeda H, Wada Y, Koshiyama H.

Intern Med. 2011;50(19):2201-5. Epub 2011 Oct 1.

17.

[Intergenerational transmission of late-adolescent adult attachment styles: does attachment recur?].

Kanemasa Y.

Shinrigaku Kenkyu. 2007 Oct;78(4):398-406. Japanese.

PMID:
18027586
19.

Heterologous expression and functional analysis of the gene cluster for the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1.

Aso Y, Nagao J, Koga H, Okuda K, Kanemasa Y, Sashihara T, Nakayama J, Sonomoto K.

J Biosci Bioeng. 2004;98(6):429-36.

PMID:
16233732
20.

A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1.

Aso Y, Okuda K, Nagao J, Kanemasa Y, Thi Bich Phuong N, Koga H, Shioya K, Sashihara T, Nakayama J, Sonomoto K.

Biosci Biotechnol Biochem. 2005 Jul;69(7):1403-10.

21.

Characterization of functional domains of lantibiotic-binding immunity protein, NukH, from Staphylococcus warneri ISK-1.

Okuda K, Aso Y, Nagao J, Shioya K, Kanemasa Y, Nakayama J, Sonomoto K.

FEMS Microbiol Lett. 2005 Sep 1;250(1):19-25.

22.

Description of complete DNA sequence of two plasmids from the nukacin ISK-1 producer, Staphylococcus warneri ISK-1.

Aso Y, Koga H, Sashihara T, Nagao J, Kanemasa Y, Nakayama J, Sonomoto K.

Plasmid. 2005 Mar;53(2):164-78.

PMID:
15737403
23.

Characterization of a gene cluster of Staphylococcus warneri ISK-1 encoding the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1.

Aso Y, Sashihara T, Nagao J, Kanemasa Y, Koga H, Hashimoto T, Higuchi T, Adachi A, Nomiyama H, Ishizaki A, Nakayama J, Sonomoto K.

Biosci Biotechnol Biochem. 2004 Aug;68(8):1663-71.

24.

[Early adult attachment styles and social adjustment].

Kanemasa Y, Daibo I.

Shinrigaku Kenkyu. 2003 Dec;74(5):466-73. Japanese.

PMID:
15029764
25.

The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene.

Arai H, Miyamoto KI, Yoshida M, Yamamoto H, Taketani Y, Morita K, Kubota M, Yoshida S, Ikeda M, Watabe F, Kanemasa Y, Takeda E.

J Bone Miner Res. 2001 Jul;16(7):1256-64.

26.

Lipid profile of Helicobacter spp.: presence of cholesteryl glucoside as a characteristic feature.

Haque M, Hirai Y, Yokota K, Mori N, Jahan I, Ito H, Hotta H, Yano I, Kanemasa Y, Oguma K.

J Bacteriol. 1996 Apr;178(7):2065-70.

27.

Studies on osmotic stability of liposomes prepared with bacterial membrane lipids by carboxyfluorescein release.

Nagamachi E, Hirai Y, Tomochika K, Kanemasa Y.

Microbiol Immunol. 1992;36(3):231-4.

28.

Membrane lipids of Mycoplasma orale: lipid composition and synthesis of phospholipids.

Hirai Y, Kukida S, Matsushita O, Nagamachi E, Tomochika K, Kanemasa Y.

Physiol Chem Phys Med NMR. 1992;24(1):21-7.

PMID:
1594658
30.

Establishment of a mouse model of cystitis and roles of type 1 fimbriated Escherichia coli in its pathogenesis.

Liao J, Tomochika K, Watanabe S, Kanemasa Y.

Microbiol Immunol. 1992;36(3):243-56.

31.

Application of an indirect immunofluorescence test for detection of Mycoplasma pneumoniae in respiratory exudates.

Hirai Y, Shiode J, Masayoshi T, Kanemasa Y.

J Clin Microbiol. 1991 Sep;29(9):2007-12.

32.

The presence of cis-9,10-methylene hexadecanoic acid in Yersinia enterocolitica.

Kanemasa Y, Nagamachi E, Shibuya S.

Microbiol Immunol. 1991;35(1):77-81.

33.

Adaptational changes of fatty acid composition and the physical state of membrane lipids following the change of growth temperature in Yersinia enterocolitica.

Nagamachi E, Shibuya S, Hirai Y, Matsushita O, Tomochika K, Kanemasa Y.

Microbiol Immunol. 1991;35(12):1085-93.

34.

An indirect immunofluorescence method for detection of Mycoplasma hominis in vaginal smears.

Hirai Y, Kanatani T, Ono M, Matsushita O, Kanemasa Y.

Microbiol Immunol. 1991;35(10):831-9.

35.

[Study of finding the optimum dose of cefetamet pivoxil in complicated urinary tract infections].

Ohmori H, Kumon H, Kanemasa Y, Hirai Y, Saito T.

Jpn J Antibiot. 1990 Dec;43(12):2102-32. Japanese. Erratum in: Jpn J Antibiot 1991 Mar;44(3):54.

PMID:
2086824
36.

Overproduction of truncated subunit a of H+-ATPase causes growth inhibition of Escherichia coli.

Eya S, Maeda M, Tomochika K, Kanemasa Y, Futai M.

J Bacteriol. 1989 Dec;171(12):6853-8.

37.

[Improvement of the membrane filter technique for enumeration of enterococci in water].

Koujima I, Kanemasa Y.

Nihon Saikingaku Zasshi. 1989 Nov;44(6):813-6. Japanese.

PMID:
2695660
38.

Lincomycin increases the half-life of beta-lactamase mRNA.

Matsushita O, Okabe A, Hayashi H, Kanemasa Y.

Antimicrob Agents Chemother. 1989 Jun;33(6):805-9.

39.

[A comparative study on lomefloxacin and norfloxacin in the treatment of acute uncomplicated cystitis].

Ohmori H, Kumon H, Suzuki K, Kamidono S, Arakawa S, Ishigami J, Tanaka H, Amano M, Fujita Y, Kanemasa Y, et al.

Jpn J Antibiot. 1989 Apr;42(4):1025-50. Japanese.

PMID:
2671424
40.
41.

Crystalline inclusion of Lactobacillus plantarum protoplast.

Tomochika K, Hirai Y, Kanemasa Y.

Microbiol Immunol. 1986;30(9):909-13. No abstract available.

42.

Extensive surface changes of Ehrlich ascites tumor cells induced by intracellular Li+.

Tomochika K, Tsuchiya T, Kanazawa H, Kanemasa Y, Futai M.

Chem Pharm Bull (Tokyo). 1985 Dec;33(12):5577-80. No abstract available.

PMID:
3841715
43.

Characterization of a glycophospholipid of Streptococcus pyogenes-derived L-form.

Okabe O, Hayashi H, Hirai Y, Kariyama R, Kanemasa Y.

Physiol Chem Phys Med NMR. 1985;17(1):5-12.

PMID:
3898157
44.
45.

Determination of surface charge of some bacteria by colloid titration.

Noda Y, Kanemasa Y.

Physiol Chem Phys Med NMR. 1984;16(4):263-74.

PMID:
6441172
46.

Etiological agents responsible for acute diarrhea in children in an urban community in Burma.

Aye T, Nyien MM, Kanemasa Y, Hayashi H.

Microbiol Immunol. 1983;27(6):551-6. No abstract available.

47.

[Protoplast formation of Lactobacillus casei induced by endo-N-acetylmuramidase].

Tomochika K, Funabashi M, Nagata A, Fujii T, Kanemasa Y.

Nihon Saikingaku Zasshi. 1982 Jul;37(4):777-85. Japanese. No abstract available.

PMID:
6816954
48.

Detection of functional group on the liposome surface by colloid titration.

Noda Y, Katayama T, Hirai Y, Hayashi H, Kanemasa Y.

Physiol Chem Phys. 1982;14(4):375-9.

PMID:
7186133
49.

Alteration in phospholipid composition of Staphylococcus aureus during formation of autoplast.

Okabe A, Hirai Y, Hayashi H, Kanemasa Y.

Biochim Biophys Acta. 1980 Jan 18;617(1):28-35.

PMID:
7353022
50.

Presence and synthesis of cholesterol in stable staphylococcal L-forms.

Hayami M, Okabe A, Sasai K, Hayashi H, Kanemasa Y.

J Bacteriol. 1979 Dec;140(3):859-63.

Supplemental Content

Loading ...
Support Center